Vireo Growth (VREOF) Income towards Parent Company (2020 - 2026)

Vireo Growth's (VREOF) quarterly Income towards Parent Company came in at -$22.5 million in Q1 2026, down 246.15% year-on-year from $15.4 million in Q1 2025, and up 33.39% quarter-over-quarter from -$33.8 million in Q4 2025.

Vireo Growth (VREOF) Income towards Parent Company (2020 - 2026) Analysis & Trends

Vireo Growth has disclosed Income towards Parent Company across 7 years of filings, most recently posting -$22.5 million for Q1 2026.

  • Income towards Parent Company for Q1 2026 came in at -$22.5 million, down 246.15% year-over-year; the trailing twelve-month figure through Mar 2026 was -$97.5 million (down 250.81% YoY), and the FY2025 annual result was -$81.5 million, down 191.06% from the prior year.
  • Income towards Parent Company came in at -$22.5 million for Q1 2026 at Vireo Growth, up from -$33.8 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of $3.8 million in Q4 2023 to a low of -$33.8 million in Q4 2025.
  • The 5-year median for Income towards Parent Company is -$7.4 million (2023), against an average of -$11.0 million.
  • Across the five-year window, Income towards Parent Company soared 214.89% in 2023 and tumbled 2134.26% in 2025, its largest moves.
  • Vireo Growth's Income towards Parent Company stood at -$3.3 million in 2022, then jumped by 214.89% to $3.8 million in 2023, then slumped by 509.08% to -$15.7 million in 2024, then sank by 115.13% to -$33.8 million in 2025, then jumped by 33.39% to -$22.5 million in 2026.
  • The last three Income towards Parent Company figures came in at -$22.5 million (Q1 2026), -$33.8 million (Q4 2025), and -$26.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn
10 Vireo Growth - - 59.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -22.50 Mn
Dec 31, 2025 -33.78 Mn
Sep 30, 2025 -26.30 Mn
Jun 30, 2025 -14.93 Mn
Mar 31, 2025 -6.50 Mn
Dec 31, 2024 -15.70 Mn
Sep 30, 2024 -4.93 Mn
Jun 30, 2024 -668,411.00
Mar 31, 2024 -6.71 Mn
Dec 31, 2023 3.84 Mn
Sep 30, 2023 -5.73 Mn
Jun 30, 2023 -7.39 Mn
Mar 31, 2023 -8.47 Mn
Dec 31, 2022 -3.34 Mn
Sep 30, 2022 -9.57 Mn
Jun 30, 2022 -6.10 Mn
Mar 31, 2022 -17.68 Mn
Dec 31, 2021 -14.09 Mn
Sep 30, 2021 -6.84 Mn
Jun 30, 2021 -6.99 Mn